[Other] Synthetic Lethality Beyond BRCA: A Phase I Study of Rucaparib and Irinotecan in Metastatic Solid Tumors With Homologous Recombination-Deficiency Mutations Beyond BRCA1/2

Marilena Post time 2024-6-17 17:17:01 | Show all posts |Read mode
Reward20points

journal:JCO Precision Oncology

Authors:Erica S. Tsang; Mallika S. Dhawan; Romain Pacaud; Scott Thomas; Jennifer Grabowsky; Lauren Wilch; Silpa Karipineni; Robin Kate Kelley; Andrew H. Ko; Eric Collisson; Jocelyn S. Chapman; Stefanie Ueda; Emily K. Bergsland; Pamela Munster

Published date:2024-6-

DOI:10.1200/po.23.00494

PDF link:https://ascopubs.org/doi/pdfdirect/10.1200/PO.23.00494

Article link:http://dx.doi.org/10.1200/po.23.00494

Article Source:American Society of Clinical Oncology (ASCO)


Remark:

Best Answer

Please adopt

View Full Content

Reply

Use magic Donate Report

All Reply1 Show all posts
ahamid1 Post time 2024-6-17 17:17:02 | Show all posts

This post has been completed

Completed attachments will be deleted within 24 hours.
Reply

Use magic Donate Report

Junior Member
  • post

  • reply

  • points

    80

Latest Reply

Return to the list